The overall goal of this proposal is to bridge two major unsolved problems in basic and translational vision research: the functional role of rhodopsin dimerization and the pathophysiological mechanisms of retinitis pigmentosa, an inherited degenerative disease of the retina. Many mutations that cause retinitis pigmentosa are in the gene encoding the G protein-coupled receptor (GPCR) rhodopsin. Recent work has shown that three rhodopsin mutations, including F45L and F220C considered in this application, fail to dimerize in vitro. The central hypothesis of this proposal is that the inability of the F45L and F220C mutants to dimerize impedes normal photoreceptor function, ultimately leading to photoreceptor degeneration. This hypothesis will be tested using knock-in mouse models bearing either the F45L or the F220C rhodopsin mutation.
Three Specific Aims are proposed. First, we will quantitatively describe the extent and time course of photoreceptor degeneration in each mouse, analyze photoreceptor ultrastructure, and examine rhodopsin trafficking. Second, we will analyze the status of rhodopsin dimerization in the native photoreceptor membranes of these mice. Third, we will investigate the ability of these mutants to support phototransduction through a combination of biochemical and electrophysiological approaches. Taken together, the proposed studies are likely to contribute to our basic understanding of the role that receptor dimerization plays in GPCR signaling and the pathophysiological mechanisms underlying visual loss in congenital blinding diseases.

Public Health Relevance

This proposed research investigates the pathophysiological mechanisms of two mutations in the G protein- coupled receptor (GPCR) rhodopsin associated with a retinal degenerative disease in humans called autosomal dominant retinitis pigmentosa. By identifying the mechanisms by which these mutations lead to photoreceptor cell death, better therapeutic interventions can be designed to treat affected patients. Additionally, the proposed studies investigate the currently unknown biological function of rhodopsin dimerization, which will provide further insight into the diversity of functional roles of GPCR dimerization.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32EY029929-03
Application #
10085239
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Agarwal, Neeraj
Project Start
2019-02-01
Project End
2022-01-31
Budget Start
2021-02-01
Budget End
2022-01-31
Support Year
3
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Duke University
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705